We have worked extremely hard this year on our research program in the clinic, the operating room, and the laboratory. Our program involves collaborators from across the U.S. and around the world. Our work has paid dividends in increasing our understanding of prostate cancer, some of which has been highlighted in the pages of QUEST.
This year, we have been especially fortunate to have been awarded two new National Cancer Institute (NCI) grants, including a SPORE grant (Specialized Program of Research Excellence) in prostate cancer to go along with our previously NCI-funded participation in the ICPCG (International Consortium for Prostate Cancer Genetics) that focuses on the familial form prostate cancer. Although these grants will be helpful in sustaining our work, they are insufficient to pay for our expensive research projects, and we need additional philanthropic funds to remain at the cutting edge in advancing our field.
Our mission - to improve patient education and eliminate or reduce suffering and death from prostate cancer - has been championed by our wonderful Board members and supporters, who have contributed to sustain our work. Please join them in making an end-of-year contribution to the Urological Research Foundation. Your generosity will improve the lives of our patients and ensure a healthier, brighter future for us, our children and our grandchildren.
William J. Catalona, M.D.
Medical Director of the Urological Research Foundation